 Home > Medical News > Medicines Company News > Skin immune biomarker testing can help predict eczema in infants

Skin immune biomarker testing can help predict eczema in infants

 Last Update: 2022-09-14
 Source: Internet
 Author: User

Tags

term life

found

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

A new study presented at the 31st European Academy of Dermatology and Pathology (EADV) congress shows that researchers have identified a neonatal immune biomarker that predicts the subsequent onset and severity

The study, titled Barrier dysfunction in Atopic newBorns, analyzed a population of 450 infants (300 term and 150 premature) to test whether skin barrier and immune biomarkers could predict the onset and severity

The analysis found that term and preterm infants with increased levels of thymus activation modulating chemokines (TARC) at 2 months of life were twice as

Using tape, the researchers collected skin cells

Dr Anne-Sofie Halling, lead author and co-researcher of the study from the University of Copenhagen Bispebjerg Hospital, commented: "To our knowledge, this is the first time that noninvasive collection of skin biomarkers can be used to predict the subsequent onset and severity

This research will help us study and develop future prevention strategies for children with high levels of TARC to help stop the development of this common and debilitating disease, which is exciting

Eczema affects up to 20% of the pediatric population, and the number of confirmed cases continues to rise

"This test is painless and easy to implement and can help us detect skin changes before eczema develops, especially for the most severe forms of

The analysis found that term and preterm infants with increased levels of thymus activation modulating chemokines (TARC) at 2 months of life were twice as

Using tape, the researchers collected skin cells

This research will help us study and develop future prevention strategies for children with high levels of TARC to help stop the development of this common and debilitating disease, which is exciting

Eczema affects up to 20% of the pediatric population, and the number of confirmed cases continues to rise

"This test is painless and easy to implement and can help us detect skin changes before eczema develops, especially for the most severe forms of

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.